Role of plasma membrane-associated AKAPs for the regulation of cardiac IK1 current by protein kinase A

• Published in: Naunyn-Schmiedeberg's archives of pharmacology 2017-05, Vol.390 (5), p.493-503
• Main Authors: Seyler, Claudia, Scherer, Daniel, Köpple, Christoph, Kulzer, Martin, Korkmaz, Sevil, Xynogalos, Panagiotis, Thomas, Dierk, Kaya, Ziya, Scholz, Eberhard, Backs, Johannes, Karle, Christoph, Katus, Hugo A., Zitron, Edgar
• Format: Article
• Language: English
• Subjects: Biomedical and Life Sciences; Biomedicine; Neurosciences; Original Article; Pharmacology/Toxicology
• ISSN: 0028-1298; 1432-1912
• DOI: 10.1007/s00210-017-1344-9

The cardiac I K1 current stabilizes the resting membrane potential of cardiomyocytes. Protein kinase A (PKA) induces an inhibition of I K1 current which strongly promotes focal arrhythmogenesis. The molecular mechanisms underlying this regulation have only partially been elucidated yet. Furthermore, the role of A-kinase anchoring proteins (AKAPs) in this regulation has not been examined to date. The objective of this project was to elucidate the molecular mechanisms underlying the inhibition of I K1 by PKA and to identify novel molecular targets for antiarrhythmic therapy downstream β-adrenoreceptors. Patch clamp and voltage clamp experiments were used to record currents and co-immunoprecipitation, and co-localization experiments were performed to show spatial and functional coupling. Activation of PKA inhibited I K1 current in rat cardiomyocytes. This regulation was markedly attenuated by disrupting PKA-binding to AKAPs with the peptide inhibitor AKAP-IS. We observed functional and spatial coupling of the plasma membrane-associated AKAP15 and AKAP79 to Kir2.1 and Kir2.2 channel subunits, but not to Kir2.3 channels. In contrast, AKAPyotiao had no functional effect on the PKA regulation of Kir channels. AKAP15 and AKAP79 co-immunoprecipitated with and co-localized to Kir2.1 and Kir2.2 channel subunits in ventricular cardiomyocytes. In this study, we provide evidence for coupling of cardiac Kir2.1 and Kir2.2 subunits with the plasma membrane-bound AKAPs 15 and 79. Cardiac membrane-associated AKAPs are a functionally essential part of the regulatory cascade determining I K1 current function and may be novel molecular targets for antiarrhythmic therapy downstream from β-adrenoreceptors.